微波消融治疗大型良性甲状腺结节的有效性:一项多中心研究
这项回顾性多中心研究纳入87例患者共87个≥4 cm的良性甲状腺结节,评估超声引导下微波消融的疗效与安全性。术后12个月平均体积缩小率76.09%,技术有效率(体积缩小率>50%)90.80%,症状评分和美容评分均显著下降。
要点
- 术后12个月平均体积缩小率76.09%,技术有效率(体积缩小率>50%)为90.80%。
- 体积缩小率与初始体积(p=.015)、环形血流(p=.010)及结节成分(p=.024)相关。
- 症状评分从4.40±0.28降至0.26±0.06,美容评分从3.22±0.10降至1.31±0.08。
核心结论
- 微波消融可作为大型良性甲状腺结节安全有效的治疗方法,能显著缩小结节体积并显著改善压迫症状和外观问题。
研究设计与样本
- 回顾性多中心研究,纳入2015年4月至2021年3月间接受微波消融的87例患者共87个≥4 cm的良性甲状腺结节。
- 在术后第1、3、6、12个月进行临床和超声检查。
- 采用多变量线性混合效应模型分析体积和体积缩小率的变化及与体积缩小率相关的潜在因素。
关键影像表现/征象
- 术后12个月平均体积较初始体积显著下降(p<.001)。
- 术后12个月平均体积缩小率为76.09%。
- 术后12个月技术有效率(体积缩小率>50%)为90.80%。
- 多因素分析显示体积缩小率与初始体积(p=.015)、环形血流(p=.010)和结节成分(p=.024)相关。
- 术后12个月平均症状评分从4.40±0.28降至0.26±0.06(p<.001),平均美容评分从3.22±0.10降至1.31±0.08(p<.001)。
诊断标准与关键数值
- 技术有效定义为体积缩小率>50%,术后12个月技术有效率为90.80%。
临床应用与阅片要点
- 原文结论认为微波消融可作为大型良性甲状腺结节安全有效的治疗方法,并已作为一种补充治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the efficacy, safety, and improvement of symptoms by ultrasound-guided microwave ablation (MWA) for patients with large benign thyroid nodules (BTNs).
METHODS: Eighty-seven patients with 87 BTNs (≥ 4 cm) treated with MWA between April 2015 and March 2021 were enrolled in this retrospective multicenter study, with clinical and ultrasound examinations performed at the 1st, 3rd, 6th, and 12th months. A multivariable linear mixed effects model was employed to explore the alterations in volume and volume reduction ratio (VRR), as well as the potential factors associated with VRR.
RESULTS: The mean age of the 87 patients was 45.69 ± 14.21 years (range 18-76 years), and the ratio of men to women was 1:4.8. The mean volumes were much decreased at the 12th month after ablation compared to the initial volumes (p < .001). The mean VRR was 76.09% at the 12th month. The technique efficacy (VRR > 50%) was 90.80% at the 12th month. A multivariate analysis revealed that VRR was related to the initial volume (p = .015), annular flow (p = .010), and nodule composition (p = .024). The mean symptomatic score decreased from 4.40 ± 0.28 to 0.26 ± 0.06 at the 12th month (p < .001). At the same time, the mean cosmetic score decreased from 3.22 ± 0.10 to 1.31 ± 0.08 (p < .001).
CONCLUSION: MWA could serve as a safe and effective therapy for large BTNs, significantly reducing the volume of BTNs and significantly improving compressive symptoms and appearance problems.
CLINICAL RELEVANCE STATEMENT: Microwave ablation could serve as a safe and effective therapy for large benign thyroid nodules, leading to significant volume reduction and satisfied symptom and cosmetic alleviation period.
KEY POINTS: • This multicenter study investigated the feasibility and safety of microwave ablation for large benign thyroid nodules. • After ablation, the nodule volume was significantly reduced, and patients' symptoms and appearance problems were significantly improved. • Microwave ablation is feasible for large benign thyroid nodules and has been a supplement treatment.
引用
- Cang YC, Fan FY, Liu Y, et al. Efficacy of microwave ablation in the treatment of large benign thyroid nodules: a multi-center study. Eur Radiol. 2024. PMID: 38546792. doi:10.1007/s00330-024-10614-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。